Cargando…

Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)—a structured summary of a study protocol for a randomized controlled study

BACKGROUND: Cigarette smoking is the leading preventable cause of premature death. Despite dedicated programmes, quit rates remain low due to barriers such as nicotine withdrawal syndrome or post-cessation weight gain. Glucagon-like peptide-1 (GLP-1) analogues reduce energy intake and body weight an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Coynel, David, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Zanchi, Davide, Erlanger, Tobias E., Christ-Crain, Mirjam, Winzeler, Bettina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120253/ https://www.ncbi.nlm.nih.gov/pubmed/37081574 http://dx.doi.org/10.1186/s13063-023-07164-9

Ejemplares similares

RF32 | PSUN59 Glucagon-Like Peptide-1 Analogues: A New Way to Quit Smoking? SKIP – a Randomised Controlled Study
por: Atila, Cihan, et al.
Publicado: (2022)

Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial
por: Lengsfeld, Sophia, et al.
Publicado: (2023)

FRI068 Gender Differences In Smoking Cessation? Results Of A Randomized Controlled Trial Of Dulaglutide-assisted Smoking Cessation
por: Baur, Fabienne, et al.
Publicado: (2023)

THU122 Effects Of A GLP-1 Agonist On Consumption Of Alcohol In Patients Treated For Smoking Cessation
por: Probst, Leila Sofia, et al.
Publicado: (2023)

GLP1 Receptor Agonists Reduce Fluid Intake in Primary Polydipsia
por: Winzeler, Bettina Felicitas, et al.
Publicado: (2021)

Empagliflozin Increases Short-Term Urinary Volume Output in Artificially Induced Syndrome of Inappropriate Antidiuresis
por: Refardt, Julie, et al.
Publicado: (2017)

The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study
por: Atila, Cihan, et al.
Publicado: (2022)

ODP313 Glucagon-Stimulated Copeptin Measurements in the Differential Diagnosis of Diabetes Insipidus: A Double-Blind Randomized Placebo-Controlled Study
por: Atila, Cihan, et al.
Publicado: (2022)

Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis
por: Refardt, Julie, et al.
Publicado: (2019)

Approach to the Patient: “Utility of the Copeptin Assay”
por: Christ-Crain, Mirjam, et al.
Publicado: (2022)

Concentrations of the Stress Hormone Copeptin Increase upon Hypoglycaemia in Patients with Type 1 Diabetes Dependent of Hypoglycaemia Awareness
por: Seelig, Eleonora, et al.
Publicado: (2013)

RF25 | PMON179 Role of Apparent Strong Ion Difference in the Differential Diagnosis of Thiazide Associated Hyponatremia
por: Monnerat, Sophie, et al.
Publicado: (2022)

SAT-066 Effect Of Interleukin-1-receptor Antagonist On Hemodynamics And Renin-angiotensin-aldosterone System In Obese Individuals
por: Urwyler, Sandrine, et al.
Publicado: (2019)

Smoking prevention in adolescents: a cross-sectional and qualitative evaluation of a newly implemented prevention program in Switzerland
por: Meienberg, Andrea, et al.
Publicado: (2021)

Chloride and Potassium Assessment Is a Helpful Tool for Differential Diagnosis of Thiazide-Associated Hyponatremia
por: Potasso, Laura, et al.
Publicado: (2023)

Exercise upregulates copeptin levels which is not regulated by interleukin-1
por: Popovic, Milica, et al.
Publicado: (2019)

Oral corticosteroids for post-infectious cough in adults: study protocol for a double-blind randomized placebo-controlled trial in Swiss family practices (OSPIC trial)
por: Merlo, Christoph, et al.
Publicado: (2020)

Copeptin is not useful as a marker of malignant disease in the syndrome of inappropriate antidiuresis
por: Winzeler, Bettina, et al.
Publicado: (2019)

Accuracy of abbreviated protocols for unattended automated office blood pressure measurements, a retrospective study
por: Vischer, Annina S., et al.
Publicado: (2021)

Improved agreement and diagnostic accuracy of a cuffless 24-h blood pressure measurement device in clinical practice
por: Socrates, Thenral, et al.
Publicado: (2021)

OR27-6 Effects of the SGLT2-Inhibitor Empagliflozin in Patients With Chronic Syndrome of Inadequate Antidiuresis (SIAD) - Results of a Double-Blind, Randomized, Placebo-Controlled, Crossover Trial
por: Berres, Manfred, et al.
Publicado: (2022)

EJE AWARD 2019: New diagnostic approaches for patients with polyuria polydipsia syndrome
por: Christ-Crain, Mirjam
Publicado: (2019)

Effect of Cuff Inflation on Blood Pressure, Arousals, Sleep Efficiency, and Desaturations: Sub-Analysis of the VAST Pilot Study
por: Socrates, Thenral, et al.
Publicado: (2023)

Copeptin: a new and promising diagnostic and prognostic marker
por: Katan, Mira, et al.
Publicado: (2008)

Breakfast: To Skip or Not to Skip?
por: Zilberter, Tanya, et al.
Publicado: (2014)

Analyzing 24-Hour Blood Pressure Measurements with a Novel Cuffless Pulse Transit Time Device in Clinical Practice—Does the Software for Heartbeat Detection Matter?
por: Kilian, Leo, et al.
Publicado: (2020)

Clinical review: The role of biomarkers in the diagnosis and management of community-acquired pneumonia
por: Christ-Crain, Mirjam, et al.
Publicado: (2010)

FGF-21 levels in polyuria-polydipsia syndrome
por: Refardt, Julie, et al.
Publicado: (2018)

OR2805 Plasma Sodium Increase Is Associated With An Increase In Bone Formation In Outpatients With Chronic SIAD—A Predefined Secondary Analysis Of The SANDx Trial
por: Monnerat, Sophie, et al.
Publicado: (2023)

The Circadian Rhythm of Copeptin, the C-Terminal Portion of Arginine Vasopressin
por: Beglinger, Svetlana, et al.
Publicado: (2017)

THU113 Psychopathological Characteristics In Patients With Arginine Vasopressin Deficiency (Central Diabetes Insipidus) And Primary Polydipsia
por: Beck, Julia, et al.
Publicado: (2023)

No obesity paradox in patients with community-acquired pneumonia – secondary analysis of a randomized controlled trial
por: Borisov, Angel N., et al.
Publicado: (2022)

Influence of Prednisone on Inflammatory Biomarkers in Community‐Acquired Pneumonia: Secondary Analysis of a Randomized Trial
por: Raess, Natalie, et al.
Publicado: (2021)

Prevalence of Admission Hyponatremia in Patients With Diabetes Treated With and Without an SGLT2 inhibitor
por: Monnerat, Sophie, et al.
Publicado: (2023)

Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study
por: Morgenthaler, Nils G, et al.
Publicado: (2005)

Correction: Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study
por: Morgenthaler, Nils G, et al.
Publicado: (2005)

Hyponatremia Intervention Trial (HIT): Study Protocol of a Randomized, Controlled, Parallel-Group Trial With Blinded Outcome Assessment
por: Refardt, Julie, et al.
Publicado: (2021)

Quitting e-cigarettes: Quit attempts and quit intentions among youth and young adults
por: Cuccia, Alison F., et al.
Publicado: (2021)

Quit Now? Quit Soon? Quit When You’re Ready? Insights About Target Quit Dates for Smoking Cessation From an Online Quit Date Tool
por: Cobb, Caroline O, et al.
Publicado: (2014)

THU112 Effect Of Protein Supplementation On Plasma Sodium Levels And Urinary Urea Excretion In Patients With Chronic Siad—A Monocentric Open-Label Proof-Of-Concept Study—The Treasure Study
por: Monnerat, Sophie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0tnnakuausnd6guvlmipim7q8p